Capstone Wealth Management (Alabama)’s Vertex Pharmaceuticals VRTX Stock Holding History

Capstone Wealth Management (Alabama)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Buy	+424	New	+$188K	0.1%	172

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Capstone Wealth Management (Alabama)'s VRTX Position: Q2 2026 in Review

Capstone Wealth Management (Alabama) opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 424 shares worth $211K. The stake represents 0.1% of the portfolio and ranks #172 among its holdings.

734 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Capstone Wealth Management (Alabama) held 424 shares of Vertex Pharmaceuticals worth $211K as of Q2 2026.
Vertex Pharmaceuticals was a new Capstone Wealth Management (Alabama) position in Q2 2026.
Vertex Pharmaceuticals made up 0.1% of Capstone Wealth Management (Alabama)'s portfolio in Q2 2026, its #172 holding.
734 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Capstone Wealth Management (Alabama)'s 13F filing for Q2 2026, filed 23 Jul 2026.